Fonderephar, Faculty of Pharmacy, 35 chemin des Maraîchers, 31062 Toulouse cedex 9, France.
Fonderephar, Faculty of Pharmacy, 35 chemin des Maraîchers, 31062 Toulouse cedex 9, France; University Paul Sabatier, Laboratoire de Génie Chimique, UMR 5503, Faculty of Pharmacy, 35 chemin des Maraîchers, 31062 Toulouse cedex 9, France.
Phytomedicine. 2016 Mar 15;23(3):307-15. doi: 10.1016/j.phymed.2015.11.016. Epub 2015 Dec 22.
Recent works present evidence of Propionibacterium acnes growing as a biofilm in cutaneous follicles. This formation of clusters is now considered as an explanation for the in vivo resistance of P. acnes to the main antimicrobials prescribed in acne vulgaris.
Our objective was to explore this hypothesis and propose a new therapeutic approach focusing on anti-biofilm activity of Myrtacine(®) New Generation (Mediterranean Myrtle extract-Botanical Expertise P. Fabre) alone or combined with antibiotics.
METHODS/RESULTS: Using in vitro models able to promote the growth of adhered bacteria, the loss of sensitivity of P. acnes biofilms (48 h) towards erythromycin and clindamycin was checked considering either sensitive or resistant strains. In the same time, the activity of Myrtacine(®) New Generation against biofilm formation and mature biofilm (48 h) was evaluated. Using a dynamic model of biofilm formation, we noted an inhibition of biofilm formation (addition of Myrtacine(®) New Generation at T 0) and a significant effect on mature biofilm (48 h) for 5 min of contact. This effect was also checked using the static model of biofilm formation for Myrtacine(®) New Generation concentrations ranging from 0.03% to 0.0001%. A significant, dose-dependent anti-biofilm effect was observed and notable even at a concentration lower than the active concentration on planktonic cells, i.e. 0.001%. Finally, the interest of the combination of Myrtacine(®) New Generation with antibiotics was explored. An enhanced efficacy was noted when erythromycin (1000 mg/l) or clindamycin (500 mg/l) was added to 0.001% Myrtacine(®), leading to significant differences in comparison to each compound used alone.
The efficiency of Myrtacine(®) New Generation on P. acnes biofilm alone or combined with antibiotics was demonstrated and can lead to consider it as a potent adjunctive product efficient during the antibiotic course for acne vulgaris treatment.
最近的研究表明,痤疮丙酸杆菌在皮肤毛囊中形成生物膜。这种集群的形成现在被认为是痤疮丙酸杆菌对痤疮主要抗生素治疗的体内耐药性的解释。
我们的目的是探索这一假说,并提出一种新的治疗方法,重点是梅塔辛(®)新一代(地中海桃金娘提取物-植物专家 P. Fabre)的抗生物膜活性,单独使用或与抗生素联合使用。
方法/结果:使用能够促进粘附细菌生长的体外模型,检查痤疮丙酸杆菌生物膜(48 小时)对红霉素和克林霉素的敏感性丧失,考虑敏感或耐药菌株。同时,评估梅塔辛(®)新一代对生物膜形成和成熟生物膜(48 小时)的活性。使用生物膜形成的动态模型,我们注意到生物膜形成的抑制(在 T0 时添加梅塔辛(®)新一代)和对成熟生物膜(48 小时)的显著影响,接触 5 分钟。在生物膜形成的静态模型中也检查了这种效果,梅塔辛(®)新一代的浓度范围为 0.03%至 0.0001%。观察到剂量依赖性的显著抗生物膜作用,甚至在低于浮游细胞活性浓度的浓度下也很明显,即 0.001%。最后,探索了梅塔辛(®)新一代与抗生素联合使用的效果。当将红霉素(1000mg/l)或克林霉素(500mg/l)添加到 0.001%的梅塔辛(®)中时,观察到增效作用,与单独使用每种化合物相比,差异显著。
证明了梅塔辛(®)新一代对痤疮丙酸杆菌生物膜的单独或联合抗生素的效果,并可考虑将其作为一种有效的辅助产品,在治疗痤疮的抗生素疗程中使用。